Citadel Advisors
AGL icon

Citadel Advisors’s Agilon Health AGL Stock Holding History

Citadel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21M Buy
+57,900
New +$3.79M ﹤0.01% 4354
2026
Q1 		– Sell
-724
Closed -$12.5K – 12883
2025
Q4 		$12.5K Sell
724
-4,988
-87% -$96.7K ﹤0.01% 12415
2025
Q3 		$147K Sell
5,712
-1,168
-17% -$44.1K ﹤0.01% 11546
2025
Q2 		$396K Sell
6,880
-416
-6% -$33.4K ﹤0.01% 9172
2025
Q1 		$790K Buy
7,296
+4,960
+212% +$432K ﹤0.01% 7474
2024
Q4 		$111K Sell
2,336
-3,656
-61% -$221K ﹤0.01% 11325
2024
Q3 		$589K Buy
5,992
+4,324
+259% +$558K ﹤0.01% 7920
2024
Q2 		$273K Buy
1,668
+404
+32% +$57.6K ﹤0.01% 9323
2024
Q1 		$193K Sell
1,264
-2,112
-63% -$351K ﹤0.01% 10378
2023
Q4 		$1.06M Buy
3,376
+2,744
+434% +$993K ﹤0.01% 6552
2023
Q3 		$281K Sell
632
-24
-4% -$10.8K ﹤0.01% 9297
2023
Q2 		$284K Sell
656
-1,316
-67% -$740K ﹤0.01% 9171
2023
Q1 		$1.17M Buy
1,972
+1,184
+150% +$663K ﹤0.01% 6435
2022
Q4 		$318K Sell
788
-12
-2% -$5.63K ﹤0.01% 9191
2022
Q3 		$468K Sell
800
-1,348
-63% -$807K ﹤0.01% 8604
2022
Q2 		$1.17M Buy
2,148
+1,804
+524% +$912K ﹤0.01% 6664
2022
Q1 		$218K Buy
344
+28
+9% +$14.4K ﹤0.01% 11311
2021
Q4 		$213K Sell
316
-300
-49% -$183K ﹤0.01% 11718
2021
Q3 		$404K Buy
+616
New +$526K ﹤0.01% 10385

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors's AGL Position: Q2 2026 in Review

Citadel Advisors opened a new position in Agilon Health (AGL) in Q2 2026: 56,045 shares worth $6.01M. The stake represents ﹤0.01% of the portfolio and ranks #4415 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in AGL as recently as Q4 2025.

Citadel Advisors first reported a position in AGL in Q2 2021 and has held it in 17 quarters since. The position peaked at $35.1M in Q2 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Citadel Advisors held 56,045 shares of Agilon Health worth $6.01M as of Q2 2026.
  • Agilon Health was a new Citadel Advisors position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4415 holding.
  • Citadel Advisors first reported a position in Agilon Health in Q2 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Agilon Health position peaked at $35.1M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.